Xyzal Approved for Younger Kids

Posted on 08/25/2009, 10:59
By -- Scott Roberts

Antihistamine sanctioned for children as young as 6 months

TUESDAY, Aug. 25 (HealthDay News) -- The antihistamine Xyzal (levocetirizine dihydrochloride) has been approved for children aged six months and older for indoor allergies and hives, drug makers UCB and Sanofi-Aventis said.

The medication, available as a liquid or pill, had been approved previously for people aged six years and older. The expanded approval also sanctions the drug's use to treat outdoor allergies in children aged two years and older.

Side effects of the medication may include fatigue, sore throat and dry mouth. Younger children may have additional adverse effects including fever, diarrhea, vomiting, ear infections and constipation, the drug makers said in a news release.

More information

The FDA has more information about this drug's approval history.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

More news in Allergy...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 3.0 / 5 (60 votes)
Rate the article:
1/52/53/54/55/5

Comments (0):

Be the first to comment on this article.

Post a comment

Name

Subject

Text in the image

Comment